M. Venturini

2.9k total citations
87 papers, 1.9k citations indexed

About

M. Venturini is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Venturini has authored 87 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 25 papers in Cancer Research and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Venturini's work include Cancer Treatment and Pharmacology (38 papers), Breast Cancer Treatment Studies (23 papers) and HER2/EGFR in Cancer Research (12 papers). M. Venturini is often cited by papers focused on Cancer Treatment and Pharmacology (38 papers), Breast Cancer Treatment Studies (23 papers) and HER2/EGFR in Cancer Research (12 papers). M. Venturini collaborates with scholars based in Italy, United Kingdom and Switzerland. M. Venturini's co-authors include Lucia Del Mastro, Gianfilippo Bertelli, R. Rosso, Ornella Garrone, D. Dini, Rita Lionetto, P. Pronzato, Massimo Costantini, Alberto Gozza and Claudia Bighin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

M. Venturini

82 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Venturini Italy 25 1.3k 371 299 281 272 87 1.9k
Gianfilippo Bertelli United Kingdom 27 1.3k 1.0× 563 1.5× 311 1.0× 364 1.3× 63 0.2× 107 2.2k
B Chevallier France 21 1.2k 0.9× 490 1.3× 176 0.6× 227 0.8× 68 0.3× 68 1.8k
Νicolas Tsavaris Greece 22 999 0.8× 149 0.4× 161 0.5× 495 1.8× 230 0.8× 87 1.7k
Anne Moore United States 14 770 0.6× 399 1.1× 132 0.4× 145 0.5× 78 0.3× 30 1.2k
Frederick Richards United States 29 1.2k 1.0× 363 1.0× 99 0.3× 497 1.8× 122 0.4× 100 2.5k
Susan Dent Canada 27 1.1k 0.9× 495 1.3× 100 0.3× 313 1.1× 259 1.0× 81 2.1k
Jamey Skillings Canada 18 1.3k 1.0× 260 0.7× 49 0.2× 514 1.8× 261 1.0× 40 2.1k
Howard M. Gross United States 27 1.4k 1.1× 530 1.4× 185 0.6× 538 1.9× 63 0.2× 55 2.6k
Ta‐Chung Chao Taiwan 22 724 0.6× 248 0.7× 128 0.4× 485 1.7× 73 0.3× 99 1.4k
Shozo Ohsumi Japan 27 1.2k 1.0× 701 1.9× 356 1.2× 373 1.3× 41 0.2× 134 2.5k

Countries citing papers authored by M. Venturini

Since Specialization
Citations

This map shows the geographic impact of M. Venturini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Venturini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Venturini more than expected).

Fields of papers citing papers by M. Venturini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Venturini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Venturini. The network helps show where M. Venturini may publish in the future.

Co-authorship network of co-authors of M. Venturini

This figure shows the co-authorship network connecting the top 25 collaborators of M. Venturini. A scholar is included among the top collaborators of M. Venturini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Venturini. M. Venturini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Venturini, M., et al.. (2023). VP286 Clinical, imaging, pathological, and molecular features of HNRNPDL-related muscular dystrophy. Neuromuscular Disorders. 33. S114–S115. 2 indexed citations
3.
Banelli, Barbara, Ida Casciano, Angela Di Vinci, et al.. (2009). Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer. Annals of Oncology. 21(6). 1237–1242. 30 indexed citations
4.
5.
Catania, Chiara, Vittorina Zagonel, Vinicio Fosser, et al.. (2008). Opinions concerning euthanasia, life-sustaining treatment and acceleration of death: results of an Italian Association of Medical Oncology (AIOM) survey. Annals of Oncology. 19(11). 1947–1954. 6 indexed citations
6.
Mastro, Lucia Del, Béatrice Dozin, Enrico Aitini, et al.. (2007). Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest–Mammella Intergruppo (GONO-MIG) Group. Annals of Oncology. 19(2). 299–307. 12 indexed citations
7.
Mastro, Lucia Del, Francesco Perrone, Lazzaro Repetto, et al.. (2005). Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer). Annals of Oncology. 16(2). 253–258. 52 indexed citations
8.
Mastro, Lucia Del, Luca Boni, M. R. Sertoli, et al.. (2005). Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Annals of Oncology. 17(1). 74–78. 78 indexed citations
9.
Lunardi, Gianluigi, Maria O. Vannozzi, Claudia Bighin, et al.. (2003). Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients. Annals of Oncology. 14(8). 1222–1226. 16 indexed citations
10.
Venturini, M.. (2002). Rational development of capecitabine. European Journal of Cancer. 38. 3–9. 35 indexed citations
11.
Bertelli, Gianfilippo, M. Venturini, Lucia Del Mastro, et al.. (2002). Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study. Annals of Oncology. 13(6). 883–888. 73 indexed citations
12.
Mastro, Lucia Del, Massimo Costantini, Gabriella Morasso, et al.. (2002). Impact of two different dose-intensity chemotherapy regimens on psychological distress in early breast cancer patients. European Journal of Cancer. 38(3). 359–366. 38 indexed citations
13.
Venturini, M., Lucia Del Mastro, Ornella Garrone, et al.. (2002). Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer. Annals of Oncology. 13(4). 546–552. 18 indexed citations
14.
Angiolini, Catia, M. Venturini, Lucia Del Mastro, et al.. (2000). Capecitabine in association with epirubicin and docetaxel as first line chemotherapy in advanced breast cancer A dose-finding study. Breast Cancer Research and Treatment. 64(1). 123. 8 indexed citations
15.
16.
Conté, Pierfranco, Editta Baldini, G. Gardin, et al.. (1996). Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO). Annals of Oncology. 7(5). 487–490. 9 indexed citations
17.
Venturini, M., Paolo Bruzzi, Lucia Del Mastro, et al.. (1996). Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer.. Journal of Clinical Oncology. 14(3). 764–773. 45 indexed citations
18.
Sertoli, M.R., Paolo Bruzzi, P. Pronzato, et al.. (1995). Randomized cooperative study of perioperative chemotherapy in breast cancer.. Journal of Clinical Oncology. 13(11). 2712–2721. 27 indexed citations
19.
Ardizzoni, Andrea, M. Venturini, M.R. Sertoli, et al.. (1994). Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer. British Journal of Cancer. 69(2). 385–391. 58 indexed citations
20.
Dini, D., et al.. (1991). Irrigation for colostomized cancer patients: a rational approach. International Journal of Colorectal Disease. 6(1). 9–11. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gianfilippo Bertelli Breakdown of academic impact, for papers by B Chevallier Breakdown of academic impact, for papers by Νicolas Tsavaris Breakdown of academic impact, for papers by Anne Moore Breakdown of academic impact, for papers by Frederick Richards Breakdown of academic impact, for papers by Susan Dent Breakdown of academic impact, for papers by Jamey Skillings Breakdown of academic impact, for papers by Howard M. Gross Breakdown of academic impact, for papers by Ta‐Chung Chao Breakdown of academic impact, for papers by Shozo Ohsumi
Rankless by CCL
2026